Ozempic ‘microdosing’ is the new weight-loss trend: Should you try it?
A new trend gaining popularity among people trying to lose weight is microdosing the diabetes medication Ozempic. Experts ...
Regeneron's Diversified Growth Makes It My Top Biopharma Pick For 2025
Regeneron Pharmaceuticals is a strong investment with robust growth potential, fueled by FDA approvals and resilient market ...
Ever-Growing USA on MSN17 小时
Mitolyn vs Puravive (2025 Review) Should You Try Purple Peel Exploit or Ice Water Hack?
Navigating an over-cluttered market of weight loss supplements can feel challenging, especially when every product claims to be the ultimate. For many of us, the struggle with weight gain is about ...
SA Asks: Which biotechs are most likely to be acquired near-term?
Last year's first quarter saw a flurry of biotech takeover deals, starting off with Johnson & Johnson (JNJ)/Ambrx, Merck (MRK)/Harpoon, GSK (GSK)/Aiolos and Novartis(NVS)/Calypso in early January.